# Elixiron Immunotherapeutics

> Elixiron Immunotherapeutics (Cayman) Limited is a clinical-stage biopharmaceutical company
> founded in 2017, with offices in Taipei, Taiwan and Cambridge, Massachusetts, developing
> precision immunotherapies for neuroinflammation, autoimmune disease and cancer. This file was
> generated by API Evangelist from the company's public website; the company does not publish
> an llms.txt of its own (https://elixiron.com/llms.txt returns 404).

**There is no API.** Elixiron Immunotherapeutics operates no developer portal, public API, SDK,
webhook surface, or machine-readable specification. Contract discovery was run on 2026-08-12
against the production host and every probe missed — see
`well-known/elixiron-immunotherapeutics-well-known.yml` for the recorded statuses.

## Company

- [Elixiron Immunotherapeutics](https://elixiron.com/): Corporate website (English / 繁體中文).
- [About Elixiron](https://elixiron.com/about.php): Company profile.
- [Management Team](https://elixiron.com/management.php): Leadership.
- [Milestones](https://elixiron.com/milestone.php): Company history.
- [Contact](https://elixiron.com/contact.php): Taipei and Cambridge, MA offices; info@elixiron.com.

## Research and development

- [Pipeline](https://elixiron.com/pipeline.php): EI-1071 (enrupatinib, small-molecule CSF-1R
  inhibitor, Alzheimer's disease), EI-001 (anti-interferon-gamma monoclonal antibody, vitiligo),
  EI-012 (anti-CD36, oncology), EI-220 (mRNA, oncology).
- [Platform](https://elixiron.com/platform.php): Drug discovery platforms.

## Investors

- [Corporate Governance](https://elixiron.com/corporate-governance.php)
- [Financial Information](https://elixiron.com/financial.php)
- [Shareholders](https://elixiron.com/shareholders.php)
- [Investor Relations](https://elixiron.com/investor.php)
- [MOPS filings](https://mops.twse.com.tw): Taiwan Market Observation Post System.

## News

- [News](https://elixiron.com/news.php): Company announcements.
- [LinkedIn](https://www.linkedin.com/company/elixiron-immunotherapeutics)

## API Evangelist profile

- [apis.yml](https://raw.githubusercontent.com/api-evangelist/elixiron-immunotherapeutics/refs/heads/main/apis.yml): APIs.json 0.20 profile.
- [Domain security probe](https://raw.githubusercontent.com/api-evangelist/elixiron-immunotherapeutics/refs/heads/main/security/elixiron-immunotherapeutics-domain-security.yml)
- [Well-known probe](https://raw.githubusercontent.com/api-evangelist/elixiron-immunotherapeutics/refs/heads/main/well-known/elixiron-immunotherapeutics-well-known.yml)